Literature DB >> 1685490

Strong primary selection for the Dw4 subtype of DR4 accounts for the HLA-DQw7 association with Felty's syndrome.

J S Lanchbury1, E E Jaeger, D M Sansom, M A Hall, P Wordsworth, J Stedeford, J I Bell, G S Panayi.   

Abstract

Felty's syndrome (FS) is a rare complication of rheumatoid arthritis (RA) previously shown to be strongly associated with HLA-DR4 and less significantly with HLA-DQw7. To map more precisely the HLA locus responsible for susceptibility to FS, we have examined HLA-DR4 and DQ beta-chain polymorphisms in FS patients and controls using restriction fragment length polymorphism analysis and polymerase chain reaction amplification in conjunction with oligonucleotide probing. The increased frequency of DR4 in FS (93% vs. 32% controls) was due almost entirely to enrichment for the Dw4 subtype (88% vs. 20% controls) with a secondary increase of the Dw14 subtype. Dw10 and Dw13 subtypes of DR4 were absent from the patient group. Increase in DQw7 frequency among DR4 FS patients could be accounted for by linkage disequilibrium between Dw4 and DQw7 alleles. Whereas susceptibility to RA is strongly associated with a conserved HLA-DR beta epitope associated with several DRB1 alleles, it is primarily the Dw4 allele which is associated with progression to Felty's syndrome. The finding that amino acid sequence variation at the DR4B1 locus rather than DQB1 is associated with development of FS will have important implications for the development of novel immunotherapies which are major histocompatibility complex allele-dependent.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1685490     DOI: 10.1016/0198-8859(91)90117-r

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  19 in total

Review 1.  [Rheumatic and hemato-/oncological disorders].

Authors:  M A Reuss-Borst
Journal:  Z Rheumatol       Date:  2005-02       Impact factor: 1.372

Review 2.  Ethnic and geographical variation in antiphospholipid (Hughes) syndrome.

Authors:  I Uthman; M Khamashta
Journal:  Ann Rheum Dis       Date:  2005-05-26       Impact factor: 19.103

Review 3.  Human leukocyte antigen polymorphisms and personalized medicine for rheumatoid arthritis.

Authors:  Hiroshi Furukawa; Shomi Oka; Kota Shimada; Atsushi Hashimoto; Shigeto Tohma
Journal:  J Hum Genet       Date:  2015-04-23       Impact factor: 3.172

Review 4.  Should patients with recent onset rheumatoid arthritis be offered genetic screening?

Authors:  D P Symmons; W E Ollier; P Brennan; A J Silman
Journal:  Ann Rheum Dis       Date:  1996-07       Impact factor: 19.103

Review 5.  To B or not to B: role of B cells in pathogenesis of arthritis in HLA transgenic mice.

Authors:  Marshall Behrens; Michele Smart; David Luckey; Harvinder Luthra; Veena Taneja
Journal:  J Autoimmun       Date:  2011-06-12       Impact factor: 7.094

6.  Linkage of rheumatoid arthritis with HLA.

Authors:  C M Deighton; P J Kelly; D J Walker
Journal:  Ann Rheum Dis       Date:  1993-09       Impact factor: 19.103

Review 7.  Prognostic markers in rheumatoid arthritis and classification of antirheumatic therapies.

Authors:  E H Choy; D L Scott
Journal:  Drugs       Date:  1995       Impact factor: 9.546

8.  Dominant clonotypes in the repertoire of peripheral CD4+ T cells in rheumatoid arthritis.

Authors:  J J Goronzy; P Bartz-Bazzanella; W Hu; M C Jendro; D R Walser-Kuntz; C M Weyand
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

9.  Examination of HLA-DR4 as a severity marker for rheumatoid arthritis in Greek patients.

Authors:  K A Boki; A A Drosos; A G Tzioufas; J S Lanchbury; G S Panayi; H M Moutsopoulos
Journal:  Ann Rheum Dis       Date:  1993-07       Impact factor: 19.103

10.  Heterogeneity of rheumatoid arthritis: from phenotypes to genotypes.

Authors:  C M Weyand; P A Klimiuk; J J Goronzy
Journal:  Springer Semin Immunopathol       Date:  1998
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.